Destination XL Group Evaluates Zodiac Partners' $0.82 Cash Offer
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Destination XL Group issued the following statement with respect to the unsolicited $0.82 per share in cash tender offer made by Zodiac Partners II on May 12, 2026: The DXL Board of Directors is evaluating the Offer with its independent financial and legal advisors in furtherance of its fiduciary duties and in light of the Company's merger agreement with FBB Holdings I. The Board will make a recommendation to shareholders in due course. DXL shareholders are advised to take no action at this time pending the Board's review of the Offer.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DXLG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DXLG
Wall Street analysts forecast DXLG stock price to rise
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.740
Low
1.30
Averages
1.30
High
1.30
Current: 0.740
Low
1.30
Averages
1.30
High
1.30
About DXLG
Destination XL Group, Inc. is a specialty retailer of big + tall men’s apparel with retail locations throughout the United States. It operates under the trade names of Destination XL, DXL, DXL Men's Apparel, DXL outlets, DXL Big + Tall, Casual Male XL, and Casual Male XL outlets. It operates approximately 247 DXL retail stores, 15 DXL outlet stores, 7 Casual Male XL retail stores, 19 Casual Male XL outlet stores, and a digital business. Its DXL retail stores, e-commerce site, and mobile application offers its customers merchandise to fit a variety of lifestyles from casual to business, young to mature, in all price ranges and in all large sizes from XL and up. In addition, it also offers a selection of shoes in sizes 10W to 18W on its websites. Its Casual Male XL retail stores primarily carry moderate-priced national brands and its own brands of casual sportswear and dresswear. It also operates Casual Male XL outlets and DXL outlets for its customers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
DXL Board Recommends Rejection of Zodiac Tender Offer
- Board Decision: The DXL Board, with the assistance of external legal and financial advisors, unanimously recommends that shareholders reject the tender offer from Zodiac Partners II, LLC, initiated on May 12, 2026, at $0.82 per share, asserting that the offer does not reflect the company's true value and is opportunistic, seemingly aimed at exploiting a period of market dislocation.
- Earnings Release Rescheduling: Due to the time required for management and the Board to review the tender offer, DXL has decided to postpone the release of its fiscal Q1 2026 financial results, originally scheduled for June 3, indicating the company's cautious approach to safeguarding shareholder interests.
- Conference Call Arrangement: DXL's CEO Harvey Kanter and CFO Peter Stratton will host a conference call on June 3 at 9:00 a.m. to discuss the financial results, with participants required to pre-register for dial-in information, reflecting the company's commitment to transparency and shareholder communication.
- Advisory Team: DXL has engaged Guggenheim Securities as its financial advisor, Greenberg Traurig as its legal advisor, and Joele Frank for strategic communications, demonstrating the company's professional support and strategic planning capabilities in responding to the tender offer.
See More
Destination XL Board Recommends Rejecting Zodiac's Tender Offer
- Board Unanimously Rejects Offer: The DXLG board, after consulting with external legal and financial advisors, unanimously recommends that shareholders reject the tender offer from Zodiac Partners II at $0.82 per share, emphasizing their commitment to maximizing shareholder value.
- Offer Deemed Opportunistic: Chairman Lionel Conacher stated that the offer is highly conditional and opportunistic, seemingly aimed at deliberately exploiting a period of market dislocation, which indicates a significant undervaluation of the company's intrinsic worth.
- Merger Progressing as Planned: The all-stock merger of equals with FullBeauty Brands is still on track, expected to close in the first half of FY26, which will consolidate the two inclusive-apparel retailers into a single DXL-listed entity.
- Stock Price Performance: As of Tuesday, DXLG shares closed at $0.73, reflecting a cautious market sentiment regarding the company's future prospects, which may impact shareholder confidence in the merger deal.
See More
DXL Evaluates Zodiac's Cash Tender Offer of $0.82 per Share
- Tender Offer Evaluation: DXL's Board of Directors is carefully assessing the unsolicited cash tender offer of $0.82 per share from Zodiac Partners II, ensuring fiduciary duties are met while considering the existing merger agreement with FullBeauty.
- Shareholder Advisory: DXL advises shareholders to refrain from taking any action during the Board's review of the offer, with a position statement to be filed within ten business days via a Schedule 14D-9 with the SEC.
- Advisory Team Composition: Guggenheim Securities is acting as DXL's financial advisor, Greenberg Traurig as legal counsel, and Joele Frank for strategic communications, providing comprehensive support throughout the evaluation process.
- Merger Agreement Context: The evaluation of this offer is closely tied to DXL's merger agreement with FullBeauty, which could significantly impact DXL's shareholder structure and future strategic direction, necessitating shareholder attention to upcoming developments.
See More
Zodiac Partners Launches Cash Tender Offer for DXL Shares
- Cash Acquisition Offer: Zodiac Partners II has proposed to acquire Destination XL Group at $0.82 per share, representing a 26% premium over the closing price of $0.6513 on May 11, 2026, with a total transaction value of approximately $46 million, providing shareholders with immediate cash value and reducing future uncertainties.
- Merger Risk Avoidance: Unlike DXL's proposed all-stock merger with Full Beauty Brands, Zodiac's cash offer mitigates the complexities and debt burdens associated with the merger, ensuring shareholders receive stable returns in an uncertain macroeconomic environment.
- Financing Assurance: Zodiac has secured a conditional financing commitment from Eclipse Business Capital, ensuring sufficient funds to cover the purchase price and associated costs, demonstrating strong confidence and execution capability for the transaction.
- Shareholder Engagement Intent: Zodiac expresses willingness to engage constructively with DXL shareholders, believing its acquisition offer is superior to the Full Beauty Brands transaction, aiming to enhance shareholder value realization by providing a cash alternative.
See More
GLP-1 Drugs Drive Growth in U.S. Apparel Spending
- Surge in Apparel Demand: Approximately 80% of GLP-1 users anticipate needing new clothing due to size changes, with a Circana survey revealing that 55% of active users have already purchased new items, indicating a fresh wave of consumer spending in the apparel market.
- Significant Market Potential: Bernstein estimates that GLP-1 users could purchase between 150 million and 700 million apparel items due to weight loss, translating to an additional $13 billion in annual spending in the U.S. apparel sector, highlighting robust market demand.
- Brands Adapting to Change: Retailers like Stitch Fix have launched targeted marketing campaigns for weight loss users, with client mentions of weight loss requests tripling over the past two years, demonstrating brands' proactive adaptation to this emerging trend.
- Shift in Consumer Behavior: An increasing number of consumers are opting for more affordable clothing during their weight loss journey, with Destination XL's CEO noting that about 25% of their customers are using GLP-1 drugs, leading to a preference for cost-effective options.
See More
DXL (DXLG) Q4 2025 Earnings Call Transcript
See More
DXL Board Recommends Rejection of Zodiac Tender Offer
- Board Decision: The DXL Board, with the assistance of external legal and financial advisors, unanimously recommends that shareholders reject the tender offer from Zodiac Partners II, LLC, initiated on May 12, 2026, at $0.82 per share, asserting that the offer does not reflect the company's true value and is opportunistic, seemingly aimed at exploiting a period of market dislocation.
- Earnings Release Rescheduling: Due to the time required for management and the Board to review the tender offer, DXL has decided to postpone the release of its fiscal Q1 2026 financial results, originally scheduled for June 3, indicating the company's cautious approach to safeguarding shareholder interests.
- Conference Call Arrangement: DXL's CEO Harvey Kanter and CFO Peter Stratton will host a conference call on June 3 at 9:00 a.m. to discuss the financial results, with participants required to pre-register for dial-in information, reflecting the company's commitment to transparency and shareholder communication.
- Advisory Team: DXL has engaged Guggenheim Securities as its financial advisor, Greenberg Traurig as its legal advisor, and Joele Frank for strategic communications, demonstrating the company's professional support and strategic planning capabilities in responding to the tender offer.
See More
Destination XL Board Recommends Rejecting Zodiac's Tender Offer
- Board Unanimously Rejects Offer: The DXLG board, after consulting with external legal and financial advisors, unanimously recommends that shareholders reject the tender offer from Zodiac Partners II at $0.82 per share, emphasizing their commitment to maximizing shareholder value.
- Offer Deemed Opportunistic: Chairman Lionel Conacher stated that the offer is highly conditional and opportunistic, seemingly aimed at deliberately exploiting a period of market dislocation, which indicates a significant undervaluation of the company's intrinsic worth.
- Merger Progressing as Planned: The all-stock merger of equals with FullBeauty Brands is still on track, expected to close in the first half of FY26, which will consolidate the two inclusive-apparel retailers into a single DXL-listed entity.
- Stock Price Performance: As of Tuesday, DXLG shares closed at $0.73, reflecting a cautious market sentiment regarding the company's future prospects, which may impact shareholder confidence in the merger deal.
See More
DXL Evaluates Zodiac's Cash Tender Offer of $0.82 per Share
- Tender Offer Evaluation: DXL's Board of Directors is carefully assessing the unsolicited cash tender offer of $0.82 per share from Zodiac Partners II, ensuring fiduciary duties are met while considering the existing merger agreement with FullBeauty.
- Shareholder Advisory: DXL advises shareholders to refrain from taking any action during the Board's review of the offer, with a position statement to be filed within ten business days via a Schedule 14D-9 with the SEC.
- Advisory Team Composition: Guggenheim Securities is acting as DXL's financial advisor, Greenberg Traurig as legal counsel, and Joele Frank for strategic communications, providing comprehensive support throughout the evaluation process.
- Merger Agreement Context: The evaluation of this offer is closely tied to DXL's merger agreement with FullBeauty, which could significantly impact DXL's shareholder structure and future strategic direction, necessitating shareholder attention to upcoming developments.
See More
Zodiac Partners Launches Cash Tender Offer for DXL Shares
- Cash Acquisition Offer: Zodiac Partners II has proposed to acquire Destination XL Group at $0.82 per share, representing a 26% premium over the closing price of $0.6513 on May 11, 2026, with a total transaction value of approximately $46 million, providing shareholders with immediate cash value and reducing future uncertainties.
- Merger Risk Avoidance: Unlike DXL's proposed all-stock merger with Full Beauty Brands, Zodiac's cash offer mitigates the complexities and debt burdens associated with the merger, ensuring shareholders receive stable returns in an uncertain macroeconomic environment.
- Financing Assurance: Zodiac has secured a conditional financing commitment from Eclipse Business Capital, ensuring sufficient funds to cover the purchase price and associated costs, demonstrating strong confidence and execution capability for the transaction.
- Shareholder Engagement Intent: Zodiac expresses willingness to engage constructively with DXL shareholders, believing its acquisition offer is superior to the Full Beauty Brands transaction, aiming to enhance shareholder value realization by providing a cash alternative.
See More
GLP-1 Drugs Drive Growth in U.S. Apparel Spending
- Surge in Apparel Demand: Approximately 80% of GLP-1 users anticipate needing new clothing due to size changes, with a Circana survey revealing that 55% of active users have already purchased new items, indicating a fresh wave of consumer spending in the apparel market.
- Significant Market Potential: Bernstein estimates that GLP-1 users could purchase between 150 million and 700 million apparel items due to weight loss, translating to an additional $13 billion in annual spending in the U.S. apparel sector, highlighting robust market demand.
- Brands Adapting to Change: Retailers like Stitch Fix have launched targeted marketing campaigns for weight loss users, with client mentions of weight loss requests tripling over the past two years, demonstrating brands' proactive adaptation to this emerging trend.
- Shift in Consumer Behavior: An increasing number of consumers are opting for more affordable clothing during their weight loss journey, with Destination XL's CEO noting that about 25% of their customers are using GLP-1 drugs, leading to a preference for cost-effective options.
See More
DXL (DXLG) Q4 2025 Earnings Call Transcript
See More
